Breakthrough in CAR-T therapy: Tumors almost completely disappear in just 5 days Breakthrough in CAR-T therapy: Tumors almost completely disappear...
Immunotherapy
CAR-T therapy: First batch of patients show improvement and stop medication! CAR-T therapy: First batch of patients show improvement and...
Who Stands to Gain the Most from Long-Term Immunotherapy Survival? Who Stands to Gain the Most from Long-Term Immunotherapy Survival?...
Study Identifies Factors Predicting Long-Term Survival Benefits with Immunotherapy Study Identifies Factors Predicting Long-Term Survival Benefits with Immunotherapy Immunotherapy has...
CAR-T Cell Therapy Achieves 100% Sustained Remission in Lupus Patients CAR-T Cell Therapy Achieves 100% Sustained Remission in Lupus Patients...
Targeting SMARCAL1: A Promising Strategy for Enhancing Cancer Immunotherapy Targeting SMARCAL1: A Promising Strategy for Enhancing Cancer Immunotherapy Cancer cells...
CAR-T cell therapy for solid tumors: Key lessons learned CAR-T cell therapy for solid tumors: Key lessons learned Chimeric antigen...
Natural Gene Mutation in Cancer Boosts CAR-T Cell Anti-Cancer Ability Hundredfold Natural Gene Mutation in Cancer Boosts CAR-T Cell Anti-Cancer...
CAR-T Therapy: Lifelong Clearance of Aging Cells Slows Aging Process CAR-T Therapy: Lifelong Clearance of Aging Cells Slows Aging Process...
Low Probability of Secondary T-Cell Malignancies After CAR-T Therapy Low Probability of Secondary T-Cell Malignancies After CAR-T Therapy, Recent Study...
FDA has mandated a top-level black box warning for all marketed CAR-T therapies, citing a potential risk of inducing malignant...
Allogeneic CAR-NK Therapy Shows Promise in Phase 1/2 Trial Allogeneic CAR-NK Therapy Shows Promise in Phase 1/2 Trial Promising Clinical...
T Cell Antigens in Cancer Immunotherapy: A Comprehensive Overview T Cell Antigens in Cancer Immunotherapy: A Comprehensive Overview In recent...
Immune Therapy-Induced Colitis: Deleting Fc Segment Emerges as a Solution Immune Therapy-Induced Colitis: Deleting Fc Segment Emerges as a Solution...
Overview of the Clinical Landscape of the Next Generation CAR-T Cell Therapy Overview of the Clinical Landscape of the Next...
Advancements and Challenges in CAR-T Therapy for T-Cell Malignant Tumors Advancements and Challenges in CAR-T Therapy for T-Cell Malignant Tumors...
Strategies to Enhance CAR-T Cell Persistence in Cancer Therapy Strategies to Enhance CAR-T Cell Persistence in Cancer Therapy Over the...
What is Chemokines in Tumor Immune Therapy? What is Chemokines in Tumor Immune Therapy? Chemokines play a crucial role in...
Factors Influencing the Efficacy of CAR-T Cell Therapy in Solid Tumors Factors Influencing the Efficacy of CAR-T Cell Therapy in...
Can CAR-T Therapy Really Cure Cancer after one decade passed? Can CAR-T Therapy Really Cure Cancer after one decade passed?...
Challenges and Higher Standards Confronting CAR-T Therapy: Complex Manufacturing and Elevated Criteria Challenges and Higher Standards Confronting CAR-T Therapy: Complex...
Decoding the Impact of Immune Inhibitory Cytokines in Tumor Immunotherapy Decoding the Impact of Immune Inhibitory Cytokines in Tumor Immunotherapy....
Will CAR-NK Cancer Therapy Surpass High-Cost CAR-T Immunotherapy? Will CAR-NK Cancer Therapy Surpass High-Cost CAR-T Immunotherapy? Breakthrough in Affordable and...
Gut Bacteria Enhance Cancer Immunotherapy: Study Reveals Potential Role of Lactobacillus reuteri Gut Bacteria Enhance Cancer Immunotherapy: Study Reveals Potential...
Hope for Patients with Autoimmune Skin Diseases through Immunotherapy Hope for Patients with Autoimmune Skin Diseases through Immunotherapy Researchers have...
FDA Investigates T-Cell Malignancy Risk in CAR-T Cell Therapy Breaking News: FDA Investigates T-Cell Malignancy Risk in CAR-T Cell Therapy...
CAR-T Cell Therapy for Solid Tumors: Key Lessons CAR-T Cell Therapy for Solid Tumors: Key Lessons Chimeric Antigen Receptor (CAR)...
Reactivation of HHV-6 Virus Found in CAR-T Cells: Implications for Cancer Treatment Reactivation of HHV-6 Virus Found in CAR-T Cells:...
Siglec Receptors in Tumor Immunity and Their Targeted Therapies Siglec Receptors in Tumor Immunity and Their Targeted Therapies In the...
Breakthrough in CAR-T Therapy for CLDN6-Positive Malignant Tumors Breakthrough in CAR-T Therapy for CLDN6-Positive Malignant Tumors "Nature Medicine": Breakthrough in...